The Glipizide Tablets, cataloged under National Stock Number 6505-01-198-0075, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Apotex Corp. Dba Apotex Corp. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 2 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-198-0075 |
| Primary Part Number | NDC60505-0142-00 |
| Item Name | Glipizide Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Apotex Corp. Dba Apotex Corp |
| Status | CANCELLED |
| Primary Container Type | BOTTLE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS GLIPIZIDE ACTIVE INGREDIENT |
| Primary Container Content Quantity | 100.000 TABLETS |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| GLUCOTROL TABLETS | Roerig Div Pfizer Inc (USA) |
| NDC60505-0142-00 PRIMARY | Apotex Corp. Dba Apotex Corp (USA) |
NSN 6505-01-198-0075 is a Glipizide Tablets, manufactured by Apotex Corp. Dba Apotex Corp, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-01-198-0075 has 2 cross-referenced part numbers: GLUCOTROL TABLETS (Roerig Div Pfizer Inc), NDC60505-0142-00 (Apotex Corp. Dba Apotex Corp).
There are 2 known substitutes for 6505-01-198-0075: 6505-01-196-6212, 6505-01-253-1901. Verify interchangeability with system specifications before substitution.
Key specifications for NDC60505-0142-00: Primary Container Type: BOTTLE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Active Medicament Medicinal Strength: 10.000 MILLIGRAMS GLIPIZIDE ACTIVE INGREDIENT; Primary Container Content Quantity: 100.000 TABLETS. 5 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-01-198-0075 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.